We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

811:HKEXXinhua Winshare Publishing & Media Co., Ltd. Class H Analysis

Data as of 2026-06-14 - not real-time

MYR 1.53

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

PGF Capital Berhad is trading at MYR 1.53, just below its 20‑day SMA of 1.54 and well under the 50‑day (1.63) and 200‑day (1.76) averages, signaling a clear bearish bias. The RSI sits at 44.7, suggesting neutral momentum, while the MACD line is negative but the histogram is slightly positive, giving a tentative bullish signal that is outweighed by the overall downtrend. Volatility is elevated at 45.8% over the past 30 days and the beta is –0.20, indicating an inverse but weak relationship with the broader market, which adds to price uncertainty.
Fundamentally, revenue has slumped 32.5% year‑on‑year, free cash flow is deeply negative, and the debt‑to‑equity ratio sits at 55.7%, raising solvency concerns. The DCF‑derived fair value of ~MYR 0.82 is far below the current price, implying the stock is overvalued despite a modest 1.96% dividend yield that rests on a low 8.3% payout – a level that may be hard to sustain given cash constraints. Recent news of “sluggish earnings” and a muted market reaction further underscores the earnings weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above the identified support level
  • Bearish technical alignment with moving averages
  • Weak earnings momentum highlighted in recent news

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Significant overvaluation relative to DCF fair value
  • Continued revenue contraction and negative free cash flow
  • Modest dividend yield but questionable sustainability

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Overvaluation combined with high debt load
  • Persistent cash generation challenges
  • Fundamental downside risk outweighing growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth-32.50%
Profit Margin15.50%
P/E Ratio12.8
ROE9.47%
ROA5.28%
Debt/Equity55.72
P/B Ratio1.1
Op. Cash FlowMYR30.7M
Free Cash FlowMYR-118269072

Technical Analysis

TrendBearish
RSI44.7
SupportMYR 1.47
ResistanceMYR 1.66
MA 20MYR 1.54
MA 50MYR 1.63
MA 200MYR 1.76
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueMYR 0.82
Target PriceMYR 2.64
Upside/Downside72.39%
GradeOvervalued
TypeValue
Dividend Yield1.96%

Risk Assessment

Beta-0.20
Volatility45.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.